These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12122314)

  • 1. Impaired spatial learning in the Morris water maze induced by serotonin reuptake inhibitors in rats.
    Majlessi N; Naghdi N
    Behav Pharmacol; 2002 May; 13(3):237-42. PubMed ID: 12122314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subchronic fluoxetine treatment on learning and memory in adolescent rats.
    Sass A; Wörtwein G
    Behav Brain Res; 2012 Mar; 228(1):169-75. PubMed ID: 22178317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning.
    Brown HD; Amodeo DA; Sweeney JA; Ragozzino ME
    J Psychopharmacol; 2012 Nov; 26(11):1443-55. PubMed ID: 22219222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks.
    Valluzzi JA; Chan K
    Behav Pharmacol; 2007 Sep; 18(5-6):507-13. PubMed ID: 17762519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.
    Sprowles JL; Hufgard JR; Gutierrez A; Bailey RA; Jablonski SA; Williams MT; Vorhees CV
    Int J Dev Neurosci; 2016 Nov; 54():39-52. PubMed ID: 27591973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
    Winter JC; Eckler JR; Doat MM; Rabin RA
    Pharmacol Biochem Behav; 2002 Dec; 74(1):95-101. PubMed ID: 12376156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenalectomy-induced granule cell degeneration in the hippocampus causes spatial memory deficits that are not reversed by chronic treatment with corticosterone or fluoxetine.
    Spanswick SC; Epp JR; Keith JR; Sutherland RJ
    Hippocampus; 2007; 17(2):137-46. PubMed ID: 17183555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats.
    Wilson MS; Hamm RJ
    Am J Phys Med Rehabil; 2002 May; 81(5):364-72. PubMed ID: 11964577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.
    Eckler JR; Doat MM; Rabin RA; Winter JC
    Life Sci; 2002 Aug; 71(11):1341-7. PubMed ID: 12106599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
    Vorhees CV; Morford LR; Graham DL; Skelton MR; Williams MT
    Behav Brain Funct; 2011 Oct; 7():41. PubMed ID: 21974752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive fluoxetine treatment affects long-term memories but not learning.
    Ampuero E; Stehberg J; Gonzalez D; Besser N; Ferrero M; Diaz-Veliz G; Wyneken U; Rubio FJ
    Behav Brain Res; 2013 Jun; 247():92-100. PubMed ID: 23511254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of striatal serotonin in fluoxetine effects on adrenocortical function and behaviour].
    Shishkina GT; Bulygina VV; Iudina AM; Tolstikova TG; Dygalo NN
    Ross Fiziol Zh Im I M Sechenova; 2007 Jul; 93(7):769-76. PubMed ID: 17912850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent fluoxetine exposure produces enduring, sex-specific alterations of visual discrimination and attention in rats.
    LaRoche RB; Morgan RE
    Neurotoxicol Teratol; 2007; 29(1):96-107. PubMed ID: 17182216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram.
    Pozzi L; Invernizzi R; Garavaglia C; Samanin R
    J Neurochem; 1999 Sep; 73(3):1051-7. PubMed ID: 10461894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal administration of fluoxetine did not alter the anxiety indicators, but decreased the locomotor activity in adult rats in the elevated plus-maze.
    Ribas VR; Aniceto HK; Martins HA; Ribas KH; Guerra-Ribas Rde M; Fraga Sdo N; Ribeiro-Ribas V; Vasconcelos CM; Viana MT; Manhaes-de-Castro R
    Arq Neuropsiquiatr; 2008 Dec; 66(4):844-7. PubMed ID: 19099123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.